| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 17 |
| 1 | ADALIMUMAB | 14 |
| 2 | PREDNISONE | 9 |
| 3 | ERGOCALCIFEROL | 8 |
| 4 | ETANERCEPT | 8 |
| 5 | ASPIRIN | 7 |
| 6 | ASPIRIN 325 MG | 7 |
| 7 | ASPIRIN 81 MG | 7 |
| 8 | CYCLOSPORINE | 7 |
| 9 | INFLIXIMAB | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUMASIRAN | 1 | 0.0026 |
| 1 | RESLIZUMAB | 1 | 0.0015 |
| 2 | TIOPRONIN | 3 | 0.0012 |
| 3 | ELAFIBRANOR | 1 | 0.0011 |
| 4 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 5 | ERDAFITINIB | 1 | 0.0008 |
| 6 | QUERCETIN | 1 | 0.0008 |
| 7 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 8 | CAPLACIZUMAB | 1 | 0.0006 |
| 9 | CLONIDINE TRANSDERMAL SYSTEM | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Reducing and Complexing Thiol [EPC] | 3 | 0.0012 |
| 2 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 3 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 5 | Cannabinoid [EPC] | 2 | 0.0002 |
| 6 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 7 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 8 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 3 | 0.0001 |